IBI112, a selective anti-IL23p19 monoclonal antibody, displays high efficacy in IL-23-induced psoriasiform dermatitis.
Li L, Wu Z, Wu M, Qiu X, Wu Y, Kuang Z, Wang L, Sun T, Liu Y, Yi S, Jing H, Zhou S, Chen B, Wu D, Wu W, Liu J.
Li L, et al. Among authors: kuang z.
Int Immunopharmacol. 2020 Dec;89(Pt B):107008. doi: 10.1016/j.intimp.2020.107008. Epub 2020 Oct 15.
Int Immunopharmacol. 2020.
PMID: 33069927